Further, a recent study comparing ovarian cancer-Tregs with melanoma-Tregs demonstrated an increased activation state and a more suppressive effect of ovarian cancer-Tregs on CD8+ T cells compared to melanoma-Tregs43. The gene discussed is CD8A; the disease is ovarian carcinoma.